ALX Oncology Holdings 주식 (NASDAQ: ALXO)

에 대한 최신 뉴스 ALX Oncology Holdings (NASDAQ:ALXO) 주식

ALX Oncology Holdings

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings Inc

On Thursday, Sen. Elizabeth Warren (D-Mass.) called out five tech giants, alleging they could gain $75 billion in tax benefits due to their close ties with the Trump administration.
What Happened: In a post on X, Warren pointed out that Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), and Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) could benefit significantly from tax cuts proposed by the Trump administration. She urged for transparency in the lobbying efforts of these companies and their potential impact on executive compensation.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Tesla, Amazon, Meta, Apple, and Alphabet could rake in $75 billion of tax giveaways after cozying up to the Trump administration. Let's find out how much they spent lobbying for this potential windfall. And let's find out how it could affect their executive compensation. <a href="https://t.co/uJFgkTsLUt">https://t.co/uJFgkTsLUt</a>
&mdash; Elizabeth Warren (@ewarren) <a href="https://twitter.com/ewarren/status/1897800449564328269?ref_src=twsrc%5Etfw">March 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Warren is pressing the CEOs of major tech firms on their lobbying efforts to restore an immediate R&amp;D tax deduction, which could be worth $75 billion retroactively. She wants details on their spending, political donations, and plans for the funds, with a response due by March 19, according to Semafor. Warren shared her letters to the likes of Elon Musk, Mark Zuckerberg, and Jeff Bezos with the publication.
See Also: <a href="https://www.benzinga.com/news/25/03/44156631/elon-musks-doge-team-has-door-slammed-on-it-at-africa-aid-agency-amid-raging-turf-war">Elon Musk&#8217;s DOGE Team Has Door Slammed On It At Africa Aid Agency Amid Raging Turf War</a>
Why It Matters: This comes in the wake of Trump&#8217;s proposed tax plan, which could reduce federal revenue by $5 trillion to $11.2 trillion over the next decade, according to estimates from the Committee for a Responsible Federal Budget. Critics warn that this could lead to <a href="https://www.benzinga.com/personal-finance/25/02/44063509/trumps-5-trillion-to-11-trillion-tax-plan-a-boost-for-growth-or-a-path-to-unprecedented-debt">severe fiscal consequences</a>, particularly in regard to rising national debt.
The Trump administration&#8217;s tax reduction plans have been <a href="https://www.benzinga.com/25/02/43774882/donald-trumps-tax-cut-could-add-46-trillion-to-deficit-says-robert-reich-emphasizing-48-billion-relief-for-top-100-us-firms-via-corporate-tax-cuts">criticized as a &#8220;shameless giveaway&#8221; </a>that could increase the deficit by $4.6 trillion. The potential tax cuts for wealthy individuals and lower corporate tax rates are likely to widen the U.S. trade deficit. The top 100 firms in the U.S. could see a tax relief of $48 billion, as per former U.S. Secretary of Labor Robert Reich.
Image via Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

News

Politics

General

AAPL

AMZN

GOOG

GOOGL

TSLA

Elizabeth Warren Wants To Know From Elon Musk, Mark Zuckerberg And Jeff Bezos How Much They Spent Lobbying For 'Potential Windfall' — Accuses Tech Giants Of 'Cozying Up' Up To Trump Administration

Wall Street is anticipating a pivotal jobs report from the Bureau of Labor and Statistics set to be released Friday morning. Here's a look at what to <a href="https://www.benzinga.com/news/econ-s/25/03/44140282/private-employment-rises-by-77000-in-february-well-below-144000-forecast-hiring-hesitancy-among-employers">watch in the report. </a>
What To Watch: The BLS will release its Employment Situation report on nonfarm payrolls and unemployment rate on Friday at 8:30 a.m. 
Economists expect the report to show the U.S. economy added 160,000 jobs in February and the unemployment rate to hold steady at 4%, per Trading Economics. 
Government employment has been trending upward, with an average monthly gain of 38,000 in 2024 and 32,000 government<a href="https://www.bls.gov/news.release/empsit.nr0.htm"> jobs added</a> in January 2025. Wall Street will be watching to see if any DOGE-related cuts are detectable in the February report.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/econ-s/25/03/44143666/us-services-sector-unexpectedly-expands-in-february-despite-slowing-job-growth">US Services Sector Unexpectedly Expands In February Despite Slowing Job Growth</a>&nbsp;
Government spending cuts and tariffs are expected to weigh on the job market in the months ahead. Comerica Economics estimates that DOGE cuts will be a 250,000 to 500,000 cumulative headwind to employment in the next six months, split between private employers who service the government and the public sector.&nbsp;
What Else: The ADP National Employment Report released Wednesday <a href="https://www.benzinga.com/news/econ-s/25/03/44140282/private-employment-rises-by-77000-in-february-well-below-144000-forecast-hiring-hesitancy-among-employers">showed</a> a significant slowdown in hiring with private employers creating 77,000 new jobs in February, the smallest number in seven months and well below forecasts of 140,000.
Bill Adams, chief economist for Comerica Bank, pointed to job cuts in trade, transportation and utilities as evidence of drag resulting from tariff fears.&nbsp;
Comerica forecasts Friday's jobs report to show employment up 150,000 with the unemployment rate rising to 4.1% from 4.0% in January.&nbsp;
"After the ADP report, risks to Comerica's forecast are to the downside," Adams said.&nbsp;
Markets Await: All three major averages ended Thursday's session lower as tariffs and geopolitical concerns weighed on investor sentiment.&nbsp;
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), tracking the S&amp;P 500, closed down 1.78% at $572.71 and the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), tracking the Nasdaq 100 index, ended the day 2.75% lower at $488.20 on Thursday.  
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44110273/trump-tariffs-will-raise-prices-within-days-target-ceo-says">Trump Tariffs Will Raise Prices &#8216;Within Days,&#8217; Target CEO Says</a></li>
</ul>
Image generated using artificial intelligence via Dall-E 3.

Broad U.S. Equity ETFs

Previews

Econ #s

Economics

ETFs

Pivotal Jobs Report Due Friday After Private Payrolls Show 'Hiring Hesitancy'

An approval rating for President Donald Trump remains unchanged in the latest Emerson College poll, while predictions of a world war increase after a recent tense meeting between the president and Ukraine President Volodymyr Zelenskyy happened<a href="https://www.benzinga.com/news/global/25/02/44053592/white-house-meeting-turns-tense-as-trump-warns-zelenskyy-youre-gambling-with-world-war-iii"> in the White House.</a>
What Happened: American<a href="https://www.benzinga.com/news/global/25/03/44101854/trump-reportedly-halts-ukraine-military-aid-pressures-zelenskyy-to-seek-peace-with-russia-amid-growing-rift"> funding support for Ukraine </a>in an ongoing war with Russia could divide American voters according to a new poll.
A March Emerson College <a href="https://emersoncollegepolling.com/march-2025-national-poll/">poll </a>of registered voters showed that Trump's job approval rating <a href="https://www.benzinga.com/25/02/43847433/trump-approval-rating-declines-in-february-unpopular-domestic-and-foreign-policy-ideas">remained unchanged </a>at 49% with his disapproval rating going up one percentage point to 43%.
One of the factors that could be hurting Trump's approval rating is his handling of the war between Russia and Ukraine. Of the voters polled, 44% disapprove of Trump's handling of the war between the two countries, with 41% approving and 15% neutral.
Approval of Trump's handling of the Russia-Ukraine war was split by party with 73% of Republicans approving, 76% of Democrats disapproving and 46% of Independents disapproving versus 35% approval.
Overall, 41% of voters said Trump's handling of foreign policy was poor, with 15% ranking his handling fair, 18% said good and 26% said excellent.
A tense meeting between Trump and Zelenskyy drew mixed reactions in the poll.
"Which country do you believe walked away the winner from the Oval Office meeting between Ukrainian President Zelenskyy and American President Trump?" the poll asked.
Overall, 46% of voters said neither the U.S. or Ukraine was the winner, with 35% saying the U.S. was the winner and 15% saying Ukraine was the winner. Four percent said both countries were equal winners.
One of the more telling results from the poll could have been a question about increased global wars.
"How likely do you think it is that a world war breaks out in the next four year?" the poll asked.
The poll found that 55% of voters think a world war is likely or somewhat likely in the next four years while 45% said it is not very likely or not at all likely.
The results for the question were mostly divided by age with the 18-29 age demographic having 70% saying it is very likely or somewhat likely. Of the age demographics, only the 60-69 and 70 and older had less than 50% of voters say a world war is not likely or somewhat likely in the next four years.
Read Also: <a href="https://www.benzinga.com/25/03/44064917/trump-says-ukraines-zelensky-is-not-ready-for-peace-after-oval-office-spat-he-disrespected-the-united-states-of-america">Trump Says Ukraine&#8217;s Zelensky Is &#8216;Not Ready For Peace&#8217; After Oval Office Spat: &#8216;He Disrespected The United States Of America&#8217;</a>
Why It's Important: The poll shows voters are fairly divided on how Trump is handling the war between Ukraine and Russia with some worry that a world war could break out.
The poll found that 55% of voters think Ukraine will likely have to give up some land to Russia. Seventeen percent believe Ukraine will become part of Russia.
A positive for Trump from the poll is 45% of voters saying the U.S. has given too much aid to Ukraine, while only 22% believe the U.S. has given too little aid to Ukraine. The remaining 33% said it was the right amount given.
While Trump has painted Zelenskyy in a negative fashion, the poll found that he has high favorable ratings among U.S. voters. Zelenskyy has a 45% favorable rating from U.S. voters compared to a 12% favorable rating for Russian President Vladimir Putin.
Among voters, 66% of Democrats view Zelenskyy favorably, followed by 42% of Independents and 28% of Republicans.
While the current negotiations between Ukraine, Russia and the U.S. will be a big foreign policy issue for Trump, voters said the top issues remain the economy, threats to democracy, immigration and health care.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/03/44169859/trump-congressional-speech-comes-up-short-in-viewership-heres-how-many-people-watched">Trump Congressional Speech Comes Up Short In Viewership: Here&#8217;s How Many People Watched</a></li>
</ul>
Photo: Shutterstock

Global

Trump's Approval Rating 48%, Voters Disapprove Handling Of Russia-Ukraine War: 55% Think World War To Happen

Warren Buffett has built a legacy on smart investing, sharp wit, and, apparently, relationship advice that's as practical as his portfolio strategy.&nbsp;
His secret to a long-lasting marriage? "If you want a marriage to last, look for someone with low expectations." Buffett dropped this gem back in 2015 at <a href="https://youtu.be/kqI29Jv-uH0?si=jE74fRBlDx3s4Z9C">Fortune's Most Powerful Women Summit</a>, and while it might sound like classic Buffett humor, there's a deeper philosophy behind it.
At first glance, it's a self-deprecating joke. But if you look at how Buffett approaches both relationships and investing, you'll see a pattern: managing expectations, minimizing risk, and playing the long game.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
<h2 class="wp-block-heading">A Lifetime of Partnership</h2>
Buffett's life has been shaped by two women—Susan Buffett and Astrid Menks—<a href="https://www.benzinga.com/24/12/42364120/warren-buffett-was-married-to-one-woman-lived-with-another-and-sent-christmas-cards-signed-by-all-3-daughter-says-not-a-bad-thing">who each played vital roles in different chapters</a> of his journey. He was married to Susan for over 50 years until her passing in 2004, and in 2006, he married Astrid, whom Susan had introduced to him years earlier. Between the two, Buffett has spent 71 years in marriage.
He has been open about how profoundly Susan influenced him. In the 2017 HBO documentary "Becoming Warren Buffett," he credited her as the driving force behind his personal and professional growth, saying, "What happened with me would not have happened without her." She encouraged his philanthropy, helped shape his public image, and supported him through his rise to becoming one of the most successful investors in history.
And yet, life doesn't always go as planned. While Buffett and Susan lived apart for decades before her passing, their bond remained strong. It was Susan who introduced him to her friend Astrid — the woman who would later become his wife. Buffett acknowledged the significance of both women in his life in "The Snowball: Warren Buffett and the Business of Life," saying, "Susie put me together, and Astrid keeps me together."
Trending: <a href="https://www.benzinga.com/money/millionaires-never-earned-six-figures-according-to-dave-ramsey">69% of Millionaires Never Earned A Six-Figure Salary – Here Are 2 Things They Do To Get Their First $1 Million, According To Dave Ramsey</a>
There's a lesson in that as well. Expectations shift. Circumstances change. Relationships evolve. What matters is choosing partners who bring out the best in you—who support, understand, and sustain you through life's twists and turns.
<h2 class="wp-block-heading">What Buffett Meant By Low Expectations</h2>
Buffett has spoken multiple times about how marriage is the most important decision a person can make. "You want to associate with people who are the kind of person you'd like to be," he said in a <a href="https://www.gatesnotes.com/a-conversation-with-warren-buffett">2017 conversation with Bill Gates</a>. "And the most important person by far in that respect is your spouse." In other words, Buffett sees marriage the way he sees business partnerships—choose wisely, because it will shape everything else in your life.
The "low expectations" part? That's Buffett's way of acknowledging that unrealistic standards can doom both marriages and investments. The key isn't to settle—it's to understand that perfection doesn't exist, whether you're picking a spouse or a stock.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>&nbsp;
<h2 class="wp-block-heading">Applying Buffett's Marriage Advice to Investing</h2>
Buffett's investment strategy mirrors his relationship philosophy in several ways:
<ul>
<li>Margin of Safety: In investing, Buffett buys stocks at a price lower than their intrinsic value to create a buffer against potential losses. In marriage, keeping expectations reasonable prevents disappointment and encourages appreciation.</li>
</ul>
<ul>
<li>Long-Term Perspective: Buffett likens wealth accumulation to rolling a snowball down a long hill, requiring patience and time. The same goes for relationships—longevity comes from consistent effort, not instant gratification.</li>
<li>Value Over Hype: Buffett doesn't chase trendy stocks; he invests in businesses with strong fundamentals. In relationships, this translates to choosing a partner based on character and compatibility rather than fleeting attraction or societal pressure.</li>
</ul>
<h2 class="wp-block-heading">Why This Approach Works</h2>
Buffett's philosophy of keeping expectations in check has helped him navigate market fluctuations and build a multi-billion-dollar empire. The same principle applies to relationships: success comes from setting realistic expectations, adapting over time, and <a href="https://www.benzinga.com/money/are-you-rich">focusing on long-term value</a> rather than short-term gains.
So whether you're picking a stock or a spouse, Buffett's advice is the same: don't expect perfection—just choose wisely, think long-term, and appreciate the real value in front of you.
Read Next:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
</ul>

Personal Finance

Warren Buffett Spent 71 Years of His Life Married — And Says The Secret to a Long-Lasting Marriage Is Finding 'Someone With Low Expectations'

Weight loss drugs have taken the world by storm and saw strong demand for the<a href="https://www.benzinga.com/25/03/44143391/novo-nordisk-boosts-wegovy-access-with-lower-pricing-and-home-delivery"> companies selling them.</a>
A new study shows that despite the increase usage of weight loss drugs, obesity is still on the rise and could hit staggering numbers in the next 25 years.
What Happened: The public support of weight loss drugs by celebrities and the<a href="https://www.benzinga.com/trading-ideas/24/12/42692809/musk-tests-mounjaro-ozempic-wegovy-which-weight-loss-drug-won-him-over"> likes of billionaires</a> like Elon Musk may have contributed to their rising use in the U.S. and worldwide.
A new study from 204 countries shows global obesity rates are climbing even with increased attention for weight loss drugs.
The study, which was funded by the Gates Foundation, found there might not be enough being done to tackle global obesity.
"The unprecedented global epidemic of overweight and obesity is a profound tragedy and a monumental social failure," research author Professor Emmanuela Gakidou from the Institute for Health Metrics and Evaluation at the University of Washington said, as reported by Reuters.
The study found that if current trends continue, more than half of global adults will be obese and around one-third of children will be obese by the year 2050. This represents totals of more than 3.8 billion adults and 746 million children according to the research.
The new research comes as obesity and overweight rates have more than doubled in the past 30 years.
Obesity can put people more at risk for diabetes, cancer and heart disease.
Read Also:<a href="https://www.benzinga.com/general/health-care/25/03/44170605/teladoc-health-partners-with-eli-liilys-lillydirect-to-expand-access-to-zepbound-for-weight-loss"> Teladoc Health Partners With Eli Liily&#8217;s LillyDirect to Expand Access to Zepbound For Weight Loss</a>
Why It's Important: The results of the study will likely need to be taken with some potential irregularities as the study did not take into account the rising demand for weight loss drugs in countries that have them readily available. The study also used body mass index as a key indicator for obesity.
Among the most impacted regions and areas that could see the fastest growth of obesity are developing countries, especially in Africa, where weight loss drugs may not be available.
In September 2024, <a href="https://www.cbsnews.com/news/obesity-rate-us-adults-cdc-data-map/">data </a>from the Centers for Disease Control and Prevention suggested the U.S.'s obesity rating was no longer growing, with around 40% of adults considered obese. This marked the first time in more than 10 years the obesity rate had not gone up.
The CDC findings came as interest and demand for weight loss drugs and diabetes drugs surged.
Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) with Wegovy and Ozempic and Eli Lilly and Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) with Mounjaro and Zepbound were among the companies benefitting from weight loss drug treatments and both stocks soared.
Studies of U.S. versus global populations could show how the availability of weight loss drug treatments is changing the statistics of current and future predictions on obesity.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/09/41036415/eli-lilly-stock-soars-in-2024-on-weight-loss-drug-success-now-the-company-wants-medical-records-o">Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments</a></li>
</ul>
Photo: Shutterstock

Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report

Acuity Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) has outperformed the market over the past 20 years by 3.94% on an annualized basis producing an average annual return of 12.06%. Currently, Acuity Brands has a market capitalization of $8.68 billion. 
Buying $100 In AYI: If an investor had bought $100 of AYI stock 20 years ago, it would be worth $970.78 today based on a price of $280.36 for AYI at the time of writing.
<h3>Acuity Brands's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741304711_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Acuity Brands 20 Years Ago Would Be Worth This Much Today

<a href="https://www.benzinga.com/personal-finance/25/02/43885487/billionaire-mark-cuban-said-the-first-step-to-getting-rich-is-giving-things-up-drink-water-eat-mac-and-cheese-and-save-every-penny">Billionaire Mark Cuban</a> isn't just talking about taxes—he's paying them. Last year, he wired $275.9 million to the IRS, and he's not complaining about it.&nbsp;
Last week, when someone on <a href="https://bsky.app/profile/mcuban.bsky.social/post/3ljbuhz3jz22u">BlueSky</a> asked, "Can't we just TAX billionaires a little bit MORE instead of firing the people controlling our nuclear weapons and fighting pandemics?" Cuban had a simple answer: "Yes."
That's it. No hedging, no dodging. Just a straightforward agreement that, instead of gutting government jobs, maybe billionaires should be taxed a little more. And considering his tax bill was larger than what thousands of Americans combined will earn in their entire lifetimes, he's not just talking—he's putting his money where his mouth is.
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/millionaires-never-earned-six-figures-according-to-dave-ramsey">69% of Millionaires Never Earned A Six-Figure Salary – Here Are 2 Things They Do To Get Their First $1 Million, According To Dave Ramsey</a></li>
</ul>
<h2 class="wp-block-heading">Cuban's Take: Billionaires Can Afford It</h2>
Cuban made it clear last year that he has no issue paying what he owes.
"I pay what I owe. This country has done so much for me, I'm proud to pay my taxes every single year," <a href="https://x.com/mcuban/status/1779905354601484638">he wrote on X</a> back in April.
And he didn't just say it—he backed it up. The $275.9 million he paid was mostly from long-term capital gains, likely tied to his <a href="https://www.benzinga.com/startups/24/08/40463542/mark-cuban-sold-his-nba-team-because-the-next-wave-of-revenue-generation-is-around-real-estate-and-a">$3.5 billion sale of the NBA's Dallas Mavericks</a>. But rather than using that as an excuse to advocate for tax cuts or loopholes, Cuban sees it as part of the deal.
"We only get to be entrepreneurs and enjoy the freedoms we have because of the men and women who dedicate their lives to protecting our country. They deserve every penny they get, and my taxes go to support them," he <a href="https://www.cnbc.com/2024/04/15/how-much-mark-cuban-pays-in-taxes.html">told CNBC</a>.
Trending: How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.
<h2 class="wp-block-heading">Government Layoffs Instead of Tax Hikes</h2>
Cuban's BlueSky post came in response to widespread government job cuts happening under the Trump administration's Department of Government Efficiency—an initiative linked to Elon Musk. DOGE has been aggressively slashing federal jobs, with estimates suggesting up to 700,000 positions could be eliminated.
The reasoning? Budget cuts. The result? Government agencies are scrambling to operate with fewer employees, even in crucial areas like public safety and health.
<h2 class="wp-block-heading">Buffett's Billion-Dollar Perspective</h2>
Cuban isn't alone in this thinking. Warren Buffett has been saying for years that billionaires and corporations should be paying more. His company, Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>, BRK.B)), paid a <a href="https://www.benzinga.com/news/25/02/44049686/warren-buffetts-subtle-message-to-trump-spend-it-wisely-after-berkshires-record-26-8-billion-tax-payment">record $26.8 billion in taxes</a>—the largest corporate tax bill in U.S. history.
See Also: <a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a>
Buffett even suggested at the 2024 Berkshire Hathaway Annual Meeting that if just 800 other companies paid the same amount in federal taxes, the entire country's tax burden would disappear:
"No other person in the United States would have had to <a href="https://www.benzinga.com/personal-finance/25/02/43975331/warren-buffett-paid-5-billion-in-taxes-and-says-if-800-other-companies-paid-their-share-no-one-else-would-have-to-pay-a-dime">pay a dime of federal taxes</a>—no income taxes, no Social Security taxes, no estate taxes."
<h2 class="wp-block-heading">Who Should Shoulder the Burden?</h2>
Cuban isn't saying billionaires should be taxed into oblivion. He's just saying there's a better way to balance the budget than firing thousands of workers. He's leading by example—paying his fair share without complaints and openly advocating for a tax system that makes sense.
With Buffett echoing similar sentiments, the question isn't whether billionaires can afford it—it's whether lawmakers will actually make them.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>

Mark Cuban Was 'Proud' To Pay His $275.9M Tax Bill Last Year — And Says 'Yes' To Taxing Billionaires More Instead Of Slashing Jobs

Barrington Research analyst Alexander Paris maintains SuRo Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSSS#NASDAQ">SSSS</a>) with a Outperform and maintains $8 price target.

Price Target

Analyst Ratings

SSSS

Barrington Research Maintains Outperform on SuRo Capital, Maintains $8 Price Target

Barrington Research analyst Vincent Colicchio maintains Climb Global Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMB#NASDAQ">CLMB</a>) with a Outperform and maintains $136 price target.

CLMB

Barrington Research Maintains Outperform on Climb Global Solutions, Maintains $136 Price Target

Wells Fargo analyst Eva Fortea Verdejo maintains ITeos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) with a Overweight and lowers the price target from $19 to $17.

ITOS

Wells Fargo Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $17

UBS analyst Trung Huynh maintains Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) with a Buy and raises the price target from $105 to $110.

INSM

UBS Maintains Buy on Insmed, Raises Price Target to $110

UBS analyst Roger Boyd maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Buy and raises the price target from $250 to $260.

UBS Maintains Buy on Zscaler, Raises Price Target to $260

Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares are trading higher in Thursday&#8217;s after-hours session after the company announced a deal to be <a href="https://in.benzinga.com/general/market-summary/25/03/44102644/walgreens-could-go-private-this-week-after-a-10-billion-deal-with-sycamore-partners-report">acquired by Sycamore Partners</a>.
What Happened: After the market close on Thursday, Walgreens announced it entered into a definitive agreement to be taken private by an entity affiliated with Sycamore Partners for $10 billion.
Walgreens shareholders will receive $11.45 per share in cash at closing. Shareholders are also eligible to receive up to $3 in cash per share from the future monetization of Walgreens&#8217; debt and equity interests in VillageMD, which includes the Village Medical, Summit Health and CityMD businesses.
&#8220;While we are making progress against our ambitious turnaround strategy, meaningful value creation will take time, focus and change that is better managed as a private company. Sycamore will provide us with the expertise and experience of a partner with a strong track record of successful retail turnarounds,&#8221; said Tim Wentworth, CEO of Walgreens.
&#8220;The WBA Board considered all these factors in evaluating this transaction, and we believe this agreement provides shareholders premium cash value, with the ability to benefit from additional value creation going forward from monetization of the VillageMD businesses.&#8221;
See Also: <a href="https://www.benzinga.com/news/earnings/25/03/44181200/broadcom-stock-surges-on-q1-earnings-beat-revenue-beat-strong-guidance-we-expect-continued-strength-in-ai-semiconductor-revenue">Broadcom Stock Surges On Q1 Earnings Beat, Revenue Beat, Strong Guidance: &#8216;We Expect Continued Strength In AI Semiconductor Revenue&#8217;</a>
Walgreens&#8217; board unanimously approved the proposed transaction, which is expected to close in the fourth quarter of 2025. Upon completion of the transaction, Walgreens will become a private company and the company&#8217;s common stock will be delisted from the Nasdaq.
Walgreens noted it will release its <a href="https://www.benzinga.com/calendars/earnings">second-quarter financial results</a> on April 8. Analysts currently expect the company to report earnings of 52 cents per share and revenue of $38.04 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
WBA Price Action: <a href="http://benzinga.com/quote/wba">Walgreens shares</a> were up 5.85% after hours, trading at $11.22 at the time of publication Thursday, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Courtesy of Walgreens Boots Alliance.

After-Hours Center

Movers

Walgreens Stock Rises As Company Inks $10B Deal To Go Private

Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) has outperformed the market over the past 20 years by 5.67% on an annualized basis producing an average annual return of 13.79%. Currently, Gilead Sciences has a market capitalization of $144.34 billion. 
Buying $100 In GILD: If an investor had bought $100 of GILD stock 20 years ago, it would be worth $1,300.17 today based on a price of $115.90 for GILD at the time of writing.
<h3>Gilead Sciences's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741302909_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GILD

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years

Retirement planning isn't exactly the most exciting topic. Until you realize you can actually get free money for investing in your future. <a href="https://www.benzinga.com/money/robinhood-review">Robinhood</a> is flipping the script on IRAs with an offer that's hard to ignore. Earn 3% extra on annual contributions when you <a href="https://www.benzinga.com/go/robinhood-gold-credit-card">subscribe to Robinhood Gold</a>, plus an uncapped 2% boost on transfers and rollovers until April 30. 
<ul>
<li><a href="https://www.benzinga.com/go/robinhood-retirement">Sign up for a Robinhood Retirement account now</a></li>
</ul>
<h2 class="wp-block-heading">Why Settle for Ordinary When You Can Boost Your IRA?</h2>
You work hard for your money, so why not make it work harder for you? With <a href="https://www.benzinga.com/go/robinhood-retirement">Robinhood's IRA</a>, every contribution gets an instant 3% boost when you&#8217;re a Robinhood Gold subscriber. And if you're rolling over funds from another retirement account, you'll get a 2% boost. No cap, no gimmicks, just extra cash added to your investments.
If you're serious about maxing out your IRA for 2025, there's another sweet deal: contribute the full amount by April 15, 2025, and you could snag an extra $420 in matching funds.
<h2 class="wp-block-heading">The Robinhood IRA Advantage</h2>
This isn't just another IRA. Robinhood is rewriting the rules with a platform built for simplicity, flexibility, and more money in your pocket.
<h3 class="wp-block-heading">Tax Advantages That Keep More Money in Your Pocket</h3>
Your <a href="https://www.benzinga.com/money/how-to-invest-your-ira">earnings in an IRA</a> grow tax-deferred or tax-free, depending on whether you choose a Traditional or Roth IRA. That means more of your money stays invested, compounding over time instead of going to the <a href="https://www.irs.gov/">IRS</a>.
<h3 class="wp-block-heading">Options Trading in a Tax-Advantaged Account</h3>
Not ready to retire from active investing? Robinhood lets qualified traders trade options on stocks and ETFs inside their IRA, with no commission or per-contract fees. That means you get the flexibility of options trading without the tax hit you'd face in a traditional brokerage account.
<h3 class="wp-block-heading">Already Have a 401(k)? Stack an IRA on Top</h3>
A 401(k) is great, but it might not be enough. If you're already maxing out your employer-sponsored plan, you can still contribute up to $7,000 in an IRA for 2025. More investment, more tax advantages, and with Robinhood, more free money with every contribution.
<h3 class="wp-block-heading">One Platform for Everything</h3>
Tired of tracking retirement accounts across different platforms? Robinhood makes it easy to find and consolidate your retirement savings in one place. Whether you&#8217;re rolling over an old 401(k) or moving funds from another IRA, the process is simple, fast, and now comes with a 2% cash boost on all transfers.
<h2 class="wp-block-heading">Who Should Consider a Robinhood IRA?</h2>
<ul>
<li>Investors who want more money upfront. Get an instant 3% boost on contributions</li>
<li>People who already <a href="https://www.benzinga.com/money/how-to-invest-your-401k">max out a 401(k)</a>. Stack an IRA on top for even greater tax benefits</li>
<li>Anyone looking for low-cost, commission-free investing. No hidden fees or per-contract costs</li>
<li>Self-employed workers or freelancers. No employer 401(k)? No problem. Robinhood's IRA puts you in control</li>
<li>Long-term investors who want to grow wealth tax-efficiently. Keep more of your gains over time</li>
</ul>
<h2 class="wp-block-heading">The Clock is Ticking</h2>
This isn't a forever deal. That 2% unlimited transfer boost disappears after April 30, and the $420 max-out match is only available if you contribute by April 15, 2025. The 3% instant match is here to stay for Robinhood Gold subscribers, but why wait? The sooner you contribute, the more time your money has to grow.
<ul>
<li><a href="https://www.benzinga.com/go/robinhood-retirement">Sign up for a Robinhood Retirement account now</a></li>
</ul>
Over 1,000,000 people have trusted Benzinga to help them choose their investing tools. Our experts are hard at work with constant updates as products &amp; markets change! Benzinga is a reader-supported publication. We may earn a commission from the advertisers associated with this article. This article is not sponsored.

Robinhood's Retirement Account Just Got Even More Interesting

Maxim Group analyst Matthew Galinko downgrades Arbe Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBE#NASDAQ">ARBE</a>) from Buy to Hold.

Downgrades

ARBE

Maxim Group Downgrades Arbe Robotics to Hold

Lake Street analyst Frank Takkinen maintains Sight Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGHT#NASDAQ">SGHT</a>) with a Hold and lowers the price target from $3 to $2.5.

SGHT

Lake Street Maintains Hold on Sight Sciences, Lowers Price Target to $2.5

Lake Street analyst Jacob Stephan maintains CompoSecure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPO#NASDAQ">CMPO</a>) with a Buy and lowers the price target from $18 to $15.

CMPO

Lake Street Maintains Buy on CompoSecure, Lowers Price Target to $15

Lake Street analyst Jaeson Schmidt maintains Identiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVE#NASDAQ">INVE</a>) with a Buy and lowers the price target from $7 to $6.

INVE

Lake Street Maintains Buy on Identiv, Lowers Price Target to $6

The Ordinary Shares are expected to begin trading on the NYSE American under the ticker symbol "MCRP" on March 7, 2025. The Offering is expected to close on March 10, 2025, subject to satisfaction of customary closing conditions.

IPOs

MCRP

Micropolis Prices IPO Of 3.875M Ordinary Shares At $4.00 Per Share; To Begin Trading On NYSE American Under Ticker Symbol 'MCRP' On March 7

Press Releases

ALX Oncology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI

Management

ALX Oncology Announces Further Additions to Leadership Team and Board of Directors, Appointing Harish Shantharam as Chief Financial Officer and Adding Barbara Klencke and Chris Takimoto to Board of Directors

Small Cap

Opinion

Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in  Patients with HER2-Positive Gastric Cancer

Comments

ALX Oncology Holdings

뉴스

에 대한 최신 뉴스 ALX Oncology Holdings (NASDAQ:ALXO) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌